Keeps Biopharma Inc. (KOSDAQ:256940)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Recycling			81.63B	-	-	-	-
OLED Business			4.58B	-	-	-	-
Pharmaceutical and Bio Business			6.39B	-	-	-	-
Cross-segment Profits			-468.46M	-	-	-	-
Industrial Automation & Controls			-	14.62B	4.26B	15.22B	14.19B
Total			92.13B	14.62B	4.26B	15.22B	14.19B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
South Korea			90.16B	14.26B	3.40B	1.77B	416.00M
China			1.97B	339.36M	575.52M	13.30B	12.34B
Other			-	16.65M	284.44M	148.46M	1.43B
Total			92.13B	14.62B	4.26B	15.22B	14.19B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error